CPE : Summary for Callon Petroleum Company Common - Yahoo Finance

U.S. Markets open in 4 hrs 48 mins

Callon Petroleum Company (CPE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.83-0.57 (-3.96%)
At close: 4:00PM EST
People also watch
CRZOCWEICRKSGYPQ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close14.40
Open14.20
Bid0.00 x
Ask0.00 x
Day's Range13.81 - 14.33
52 Week Range5.74 - 18.53
Volume3,569,533
Avg. Volume5,240,631
Market Cap2.78B
Beta1.72
PE Ratio (TTM)-6.75
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com8 days ago

    Correction in Callon Petroleum Has Likely Run Its Course

    Aggressive traders could go long here.

  • Market Realist9 days ago

    Oil Sector: Did Oil-Weighted Stocks Outperformed Oil?

    On February 11, 2016, US crude oil touched a 12-year low. From February 11, 2016, to February 13, 2017, US crude oil active futures contracts rose 101.9%.

  • PR Newswire10 days ago

    Callon Petroleum Company Announces Closing of Core Delaware Basin Acquisition

    NATCHEZ, Miss., Feb. 13, 2017 /PRNewswire/ -- Callon Petroleum Company (CPE) ("Callon" or the "Company") today announced the closing of its previously announced acquisition of oil and natural gas assets in the southern Delaware Basin from American Resource Development LLC. On February 13, 2017, the Company completed the acquisition of approximately 16,700 net surface acres in Ward and Pecos Counties, Texas, comprised of an initially disclosed amount of 16,098 net acres and an incremental 590 net acres acquired between signing and closing of the transaction that are either within or contiguous to the Ward County footprint. Inclusive of the incremental acreage and the purchase of the midstream assets of Ameredev Midstream Development LLC, total cash consideration paid for the acquisition was $633 million, subject to customary purchase price adjustments.